Supernus announces Q2 2025 earnings release and conference call on Aug 5, 2025

SUPERNUS PHARMACEUTICALS, INC.

Press release states Q2 2025 results will be reported after market close on August 5, 2025.
Conference call with President/CEO Jack Khattar and CFO Tim Dec on August 5 at 4:30 p.m. ET.
No preliminary financial results or guidance are provided in this announcement.

item 2.02 item 9.01

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-25-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.